Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine

Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Bona, Danilo, Miniello, Andrea, Nettis, Eustachio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742018/
https://www.ncbi.nlm.nih.gov/pubmed/36503530
http://dx.doi.org/10.1186/s12948-022-00179-8
_version_ 1784848441254346752
author Di Bona, Danilo
Miniello, Andrea
Nettis, Eustachio
author_facet Di Bona, Danilo
Miniello, Andrea
Nettis, Eustachio
author_sort Di Bona, Danilo
collection PubMed
description Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2 vaccines have been reported in literature since the beginning of the COVID-19 pandemic, but only few times SDRIFE-like eruptions have been described in this context. We discuss here a case of SDRIFE-like eruption following the second dose of Oxford-Astrazeneca Vaxzevria vaccine.
format Online
Article
Text
id pubmed-9742018
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97420182022-12-12 Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine Di Bona, Danilo Miniello, Andrea Nettis, Eustachio Clin Mol Allergy Letters to the Editor Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2 vaccines have been reported in literature since the beginning of the COVID-19 pandemic, but only few times SDRIFE-like eruptions have been described in this context. We discuss here a case of SDRIFE-like eruption following the second dose of Oxford-Astrazeneca Vaxzevria vaccine. BioMed Central 2022-12-12 /pmc/articles/PMC9742018/ /pubmed/36503530 http://dx.doi.org/10.1186/s12948-022-00179-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letters to the Editor
Di Bona, Danilo
Miniello, Andrea
Nettis, Eustachio
Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine
title Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine
title_full Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine
title_fullStr Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine
title_full_unstemmed Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine
title_short Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine
title_sort systemic drug-related intertriginous and flexural exanthema-like eruption after oxford-astrazeneca covid-19 vaccine
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742018/
https://www.ncbi.nlm.nih.gov/pubmed/36503530
http://dx.doi.org/10.1186/s12948-022-00179-8
work_keys_str_mv AT dibonadanilo systemicdrugrelatedintertriginousandflexuralexanthemalikeeruptionafteroxfordastrazenecacovid19vaccine
AT minielloandrea systemicdrugrelatedintertriginousandflexuralexanthemalikeeruptionafteroxfordastrazenecacovid19vaccine
AT nettiseustachio systemicdrugrelatedintertriginousandflexuralexanthemalikeeruptionafteroxfordastrazenecacovid19vaccine

Ejemplares similares